Form 4: Caleres Executive Plans Future Restricted Stock Grant

Caleres' Division President, Brian P. Costello, has a pre-planned grant of 12,962 shares of restricted common stock scheduled for September 8, 2025, vesting over two to three years.

Summary

• Brian P. Costello, Division President of Famous Footwear at Caleres Inc. (CAL), is scheduled to receive a grant of 12,962 shares of common stock on September 8, 2025.
• This transaction is a pre-planned acquisition of restricted stock, indicated by the Rule 10b5-1(c) checkbox, and is reported on a Form 4 filed on September 9, 2025.
• The restricted stock will vest in two tranches: 50% after two years (September 8, 2027) and the remaining 50% after three years (September 8, 2028).
• Following this planned transaction, Costello's beneficial ownership of common stock will increase to 24,604 shares.
• The acquisition price for these shares is $0, which is typical for restricted stock grants.

Sentiment

Score: 7

Explanation: The planned restricted stock grant to a key executive is a standard compensation practice aimed at aligning interests and retaining talent. It does not introduce new material information that would significantly alter the company's fundamental outlook or stock valuation, hence a neutral to slightly positive sentiment.

Positives

• The grant of restricted stock aligns the executive's long-term interests with those of shareholders, incentivizing sustained performance.
• It serves as a retention incentive for a key executive, Brian P. Costello, who leads the Famous Footwear division.
• The use of a Rule 10b5-1 plan indicates a pre-planned, transparent approach to executive compensation, adhering to good corporate governance practices.

Negatives

• The grant represents future dilution for existing shareholders, although the amount of 12,962 shares is relatively small.
• The shares have no immediate cash value to the executive until they vest, tying compensation to future employment and stock performance.

Risks

• Forfeiture Risk: The executive risks forfeiting the unvested shares if employment with Caleres Inc. terminates before the vesting dates.
• Market Risk: The value of the shares upon vesting is subject to the future market price of Caleres Inc. common stock, which can fluctuate.
• Dilution Risk: While minor, the issuance of new shares for compensation can lead to slight dilution for existing shareholders over time.

Future Outlook

The planned grant implies continued employment and strategic importance of Brian P. Costello to Caleres Inc. for at least the next three years, reinforcing stability in executive leadership.

Industry Context

Equity grants, particularly restricted stock with multi-year vesting, are a common component of executive compensation packages across various industries, including retail and footwear. These grants are designed to incentivize long-term performance and retention. The use of a Rule 10b5-1 plan for such grants is also a standard practice for managing insider trading compliance and demonstrating transparency.

Comparison to Industry Standards

• The structure of restricted stock grants with multi-year vesting schedules is a common practice in executive compensation across the retail and consumer goods sectors, similar to companies like Nike, Foot Locker, or Genesco.
• The grant size of 12,962 shares for a division president is within typical ranges for companies of Caleres' market capitalization, aiming to provide meaningful long-term incentives without excessive dilution.
• The use of a Rule 10b5-1 plan for pre-scheduled equity transactions is a widely adopted corporate governance best practice to mitigate concerns about insider trading.

Stakeholder Impact

• Shareholders: Minor future dilution from the issuance of new shares; improved alignment of executive interests with long-term shareholder value.
• Employees: May signal stability in executive leadership and a commitment to long-term incentives within the company.
• Executive (Brian P. Costello): Receives a significant long-term equity incentive, subject to vesting conditions and continued employment.

Next Steps

• The grant of 12,962 shares of common stock is scheduled to occur on September 8, 2025.
• The first tranche of 50% of the restricted stock will vest on September 8, 2027.
• The second tranche of 50% of the restricted stock will vest on September 8, 2028.

Key Dates

Recommendation

This Form 4 reports a pre-planned future equity grant to an executive, which is a standard compensation practice and does not provide new material information to alter the investment thesis for Caleres Inc. The transaction is scheduled for a future date and is part of a Rule 10b5-1 plan, indicating routine corporate governance rather than a significant operational or financial event that would warrant a change in recommendation.

Keywords

Caleres, CAL, Brian P Costello, Famous Footwear, SEC Form 4, Insider Transaction, Restricted Stock, Equity Grant, Executive Compensation, 10b5-1 Plan